Alopecia Areata Clinical Trials
Alopecia Areata clinical trials study new biologics, small-molecule drugs, and treatment approaches for alopecia Areata and related immune or inflammatory conditions. Corterve gathers actively recruiting Alopecia Areata studies from ClinicalTrials.gov so you can browse by location and eligibility. This is general information, not medical advice — talk with your specialist before enrolling in a study.
Recruiting Alopecia Areata studies
- A Study to Evaluate the Safety and Effectiveness of Upadacitinib Tablets in Adult and Adolescent Participants With Severe Alopecia AreataNCT06012240PHASE3AbbVieBirmingham, Alabama
- Characterization And Clinical Outcomes of AA Patients Treated With RitlecitinibNCT06531109PfizerBirmingham, Alabama
- A Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of ALD-102 Solution in Subjects With Alopecia AreataNCT06826196PHASE1, PHASE2Aldena TherapeuticsThousand Oaks, California
- Treatment of Atopic Dermatitis and Alopecia Areata With Abrocitinib in Individuals With Down SyndromeNCT07242638PHASE2Icahn School of Medicine at Mount SinaiNew York, New York
- Intralesional Cyclosporine for Alopecia AreataNCT07029204EARLY_PHASE1University of California, DavisSacramento, California
- CorEvitas Alopecia Areata (AA) Safety and Effectiveness RegistryNCT05745389CorEvitasWaltham, Massachusetts
- Evaluate the Efficacy and Safety of Ruxolitinib on Hair Regrowth in Patients With Autoimmune Polyendocrinopathy Candidiasis Ectodermal Dystrophy (APECED)-Associated Alopecia AreataNCT05398809PHASE2National Institute of Allergy and Infectious Diseases (NIAID)Bethesda, Maryland
- Evaluation of Microbiota Transplant Therapy in Patients With Alopecia AreataNCT06747611PHASE2University of MinnesotaMinneapolis, Minnesota
- Dupilumab in the Treatment of Pediatric Alopecia AreataNCT05866562PHASE2Icahn School of Medicine at Mount SinaiIrvine, California
- Regeneron AA Multicenter (Dupilumab)NCT05551793PHASE2Emma GuttmanIrvine, California
- CorEvitas International Adolescent Alopecia Areata (AA) Drug Safety and Effectiveness RegistryNCT06562270CorEvitasWaltham, Massachusetts
- A Study of LY4005130 in Adult Participants With Severe Alopecia Areata (Hair Loss)NCT07533006PHASE2Eli Lilly and CompanyFremont, California
Alopecia Areata trials by state
Alopecia Areata trials by metro
Frequently asked questions
- How do I find recruiting Alopecia Areata clinical trials?
- Corterve aggregates actively recruiting Alopecia Areata studies from the public ClinicalTrials.gov registry. Browse the studies listed on this page or take a free health assessment to see trials you may qualify for based on your profile.
- Are Alopecia Areata clinical trials free to join?
- Study participation is typically free — research sponsors cover the cost of the investigational treatment and study-related visits. Many trials also compensate participants for time and travel. Details vary by study.
- Who can take part in a Alopecia Areata clinical trial?
- Each study has its own eligibility criteria (for example age, disease stage, and prior treatments). This page is general information and not medical advice; discuss any specific trial with your healthcare provider to confirm whether it is appropriate for you.